Literature DB >> 17407972

Differential protein expression patterns obtained by mass spectrometry can aid in the diagnosis of Hodgkin's disease.

Paulo Costa Carvalho1, Maria da Gloria Costa Carvalho, Wim Degrave, Sergio Lilla, Gilberto De Nucci, Raul Fonseca, Nelson Spector, Juliane Musacchio, Gilberto Barbosa Domont.   

Abstract

More than 90% of patients with cancer, if diagnosed early, can be promptly treated; however diagnosis usually occurs after cancer cells have metastasized. Recent technological advances in mass spectrometry challenges the field of machine learning to model such high dimensional datasets for clinical diagnosis and prognosis. Here we use support vector machines recursive feature elimination to hunt for protein expression patterns in the serum mass spectra of Hodgkin's disease (HD) patients and control subjects (CS) that could aid in diagnosing-the disease. Based on eight selected features, support vector machines was able to correctly classify among all CS and HD patients based on the leave-one-out. We also correctly classified an independent dataset, acquired from the same samples, with the previously generated SVM model.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17407972

Source DB:  PubMed          Journal:  J Exp Ther Oncol        ISSN: 1359-4117


  3 in total

1.  Application of MALDI imaging for the diagnosis of classical Hodgkin lymphoma.

Authors:  Kristina Schwamborn; René C Krieg; Peggy Jirak; German Ott; Ruth Knüchel; Andreas Rosenwald; Axel Wellmann
Journal:  J Cancer Res Clin Oncol       Date:  2010-02-21       Impact factor: 4.553

2.  Identifying differences in protein expression levels by spectral counting and feature selection.

Authors:  P C Carvalho; J Hewel; V C Barbosa; J R Yates
Journal:  Genet Mol Res       Date:  2008-04-15

3.  PatternLab for proteomics: a tool for differential shotgun proteomics.

Authors:  Paulo C Carvalho; Juliana S G Fischer; Emily I Chen; John R Yates; Valmir C Barbosa
Journal:  BMC Bioinformatics       Date:  2008-07-21       Impact factor: 3.169

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.